David Murray

13.5k total citations · 3 hit papers
286 papers, 9.7k citations indexed

About

David Murray is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, David Murray has authored 286 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Molecular Biology, 77 papers in Hematology and 62 papers in Oncology. Recurrent topics in David Murray's work include DNA Repair Mechanisms (48 papers), Multiple Myeloma Research and Treatments (39 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). David Murray is often cited by papers focused on DNA Repair Mechanisms (48 papers), Multiple Myeloma Research and Treatments (39 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). David Murray collaborates with scholars based in United States, Canada and Italy. David Murray's co-authors include Razmik Mirzayans, Gökhan S. Hotamışlıgil, Bruce M. Spiegelman, Lisa Choy, Bonnie Andrais, Laurence J. Eckel, David F. Kallmes, Jennifer S. McDonald, Robert J. McDonald and Mark E. Jentoft and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

David Murray

279 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

2015 1.0k citations David Murray et al. profile →
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

1994 968 citations David Murray et al. profile →
Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors

1995 549 citations David Murray et al. profile →

Peers

Countries citing papers authored by David Murray

Since Specialization

Citations

This map shows the geographic impact of David Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Murray more than expected).

Fields of papers citing papers by David Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Murray. The network helps show where David Murray may publish in the future.

Co-authorship network of co-authors of David Murray

This figure shows the co-authorship network connecting the top 25 collaborators of David Murray. A scholar is included among the top collaborators of David Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Murray. David Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B-123 Clinical Implication of Light Chain Fragmentation in Patients with Monoclonal Gammopathies 2025 ·Clinical Chemistry ·Joseph C. Wu, (unknown), Patrick M. Vanderboom, (unknown), Mindy Kohlhagen, (unknown), James Larkin, Surendra Dasari, Angela Dispenzieri, Maria Alice V. Willrich, David Murray	1
2	Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and Rajaraman 2024 ·Cancers ·Razmik Mirzayans, David Murray	2
3	Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State 2024 ·Blood ·Adam J. Kanack, (unknown), (unknown), (unknown), Geoffrey D. Wool, (unknown), Mouhamed Yazan Abou‐Ismail, Kristi J. Smock, David L. Green, Krishna Gundabolu, (unknown), Mindy Kohlhagen, David Murray, (unknown)	0
4	Comparison of 2 Free Light Chain Assays: Performance of the Free Light Chain Ratio as a Risk Factor for MGUS Progression 2024 ·Clinical Chemistry ·Qian Wang, (unknown), Vanessa Pazdernik, Dirk R. Larson, (unknown), Surendra Dasari, S. Vincent Rajkumar, Angela Dispenzieri, David Murray, Maria Alice V. Willrich	0
5	Applications of Mass Spectrometry Proteomic Methods to Immunoglobulins in the Clinical Laboratory 2024 ·Clinical Chemistry ·David Murray, Maria Alice V. Willrich	2
6	Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance 2023 ·The Journal of Applied Laboratory Medicine ·(unknown), Maria Alice V. Willrich, Melissa R. Snyder, Surendra Dasari, Taxiarchis Kourelis, S. Vincent Rajkumar, Shaji Kumar, Angela Dispenzieri, David Murray	5
7	Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti‐CD38 monoclonal antibody 2023 ·European Journal Of Haematology ·Abhishek Seth, David Murray, Francis K. Buadi, Morie A. Gertz, (unknown), Shaji Kumar, Wilson I. Gonsalves	5
8	Analysis of monoclonal immunoglobulins from bone marrow plasma cells using immunopurification and LC-MS 2023 ·SHILAP Revista de lepidopterología ·David R. Barnidge, Angela Dispenzieri, Dragan Jevremović, David Murray	0
9	Utilizing Mass Spectrometry to Detect and Isotype Monoclonal Proteins in Urine: Comparison to Electrophoretic Methods 2023 ·Clinical Chemistry ·(unknown), Mindy Kohlhagen, Surendra Dasari, Maria Alice V. Willrich, Taxiarchis Kourelis, Angela Dispenzieri, David Murray	5
10	Bringing mass spectrometry into the care of patients with multiple myeloma 2022 ·International Journal of Hematology ·David Murray	16
11	Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report 2021 ·Blood Cancer Journal ·David Murray, Noemí Puig, Sigurður Y. Kristinsson, Saad Z. Usmani, Angela Dispenzieri, Giada Bianchi, Shaji Kumar, Wee Joo Chng, Roman Hájek, Bruno Paiva, Anders Waage, S. Vincent Rajkumar, Brian G.M. Durie	92
12	Clearing drug interferences in myeloma treatment using mass spectrometry 2021 ·Clinical Biochemistry ·Mindy Kohlhagen, John R. Mills, Maria Alice V. Willrich, Surendra Dasari, Angela Dispenzieri, David Murray	13
13	Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down de novo sequencing 2020 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Valerie J. Winton, Rafael D. Melani, Lissa C. Anderson, John P. McGee, Luis F. Schachner, David R. Barnidge, David Murray, H. Denis Alexander, David S. Gibson, Michael J. Deery, Feargal McNicholl, Joseph McLaughlin, Neil L. Kelleher, Paul M. Thomas	5
14	Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis 2019 ·British Journal of Haematology ·Surbhi Sidana, Nidhi Tandon, Morie A. Gertz, Angela Dispenzieri, Marina Ramı́rez-Alvarado, David Murray, Taxiarchis Kourelis, Francis K. Buadi, Prashant Kapoor, Wilson I. Gonsalves, Rahma Warsame, Martha Q. Lacy, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar, Nelson Leung	14
15	Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement 2019 ·Blood Cancer Journal ·David Murray, Shaji Kumar, Robert A. Kyle, Angela Dispenzieri, Surendra Dasari, Dirk R. Larson, Celine M. Vachon, James R. Cerhan, S. Vincent Rajkumar	56
16	Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer 2019 ·Molecular Cancer Therapeutics ·Xiaoyun Tang, Melinda Wuest, Matthew G.K. Benesch, Jennifer Dufour, Yuanyuan Zhao, Jonathan M. Curtis, (unknown), Bertrand Heckmann, David Murray, Frank Wuest, David N. Brindley	42
17	Monitoring free light chains in serum using mass spectrometry 2016 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·David R. Barnidge, Angela Dispenzieri, Giampaolo Merlini, Jerry A. Katzmann, David Murray	31
18	Single-nucleotide polymorphisms studied for associations with urinary toxicity from 125I prostate brachytherapy implants 2014 ·Brachytherapy ·Nawaid Usmani, (unknown), Kevin Martell, (unknown), Sunita Ghosh, Nadeem Pervez, John Pedersen, Don Yee, Albert Murtha, John Amanie, Ron S. Sloboda, David Murray, Matthew Parliament	6
19	Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: Effects on cell survival, DNA repair, and cell recovery 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Lorie L. Hughes, (unknown), Tyvin A. Rich, David Murray	25
20	Probes for the b-32 protein hybridize to loci on 7L and 8L. 1990 ·Hank W. Bass, Paul H. Sisco, David Murray, Rebecca S. Boston	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact